Mallinckrodt Pharmaceuticals is a multibillion dollar specialty pharmaceutical company focused on their mission: Managing Complexity. Improving Lives. They provide medicines to address unmet patient needs, stemming from 150 years of using unique strengths, experience and expertise to help improve people’s lives.
Xofigo (Ra-223 dichloride) is a therapeutic radiopharmaceutical owned by Bayer Consumer Care. Mallinckrodt Medical BV will act as a logistic service provider for labelling, packaging and transport of the product to countries and end-users. The project was to design, build and validate a labelling and packaging line.